Ontology highlight
ABSTRACT: Introduction
Cure rates for pediatric acute lymphoblastic leukemia (ALL) have reached an all-time high (>90%); however, neurocognitive difficulties continue to affect quality of life in at least a subset of survivors. There are relatively few quantitative neuroimaging studies in child and adolescent ALL survivors treated with chemotherapy only. Use of different outcome measures or limited sample sizes restrict our ability to make inferences about patterns of brain development following chemotherapy treatment. In this study, we used magnetic resonance imaging (MRI) to evaluate brain outcomes in ALL survivors, comparing against a group of typically developing, cancer free peers.Materials and methods
Participants included 71 ALL survivors, on average 8 years after diagnosis an
SUBMITTER: van der Plas E
PROVIDER: S-EPMC7522853 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature